supported by the National Key Research and Development Program of China(2022YFA1105304);the National Natural Science Foundation of China(T2225003 and 61927805);the Nanjing Medical Science and Technique Development Foundation(ZKX21019);the Clinical Trials from Nanjing Drum Tower Hospital(2022-LCYJ-ZD-01);the Jiangsu Funding Program for Excellent Postdoctoral Talent(2023ZB032);the Natural Science Foundation of Jiangsu Province(BK20240223);the Project of Institute of Chinese Medicine of Nanjing University(ICM2024011);the Aid Project of Nanjing Drum Tower Hospital Health,Education&Research Foundation.
The emerging messenger RNA(mRNA)nanomedicines have sprung up for disease treatment.Developing targeted mRNA nanomedicines has become a thrilling research hotspot in recent years,as they can be precisely delivered to s...
supported by the National Natural Science Foundation of China(Nos.82073782 and 82241002)。
Pure drug nanomedicines(PDNs)encompass active pharmaceutical ingredients(APIs),including macromolecules,biological compounds,and functional components.They overcome research barriers and conversion thresholds associat...
supported by the Postdoctoral Fellowship Program of CPSF(No.GZC20230333,China).
Nanomedicines have revolutionized disease prevention,diagnosis,and treatment.Since the approval of Liposomal doxorubicin(Doxil)in 1995,various nanomedicines have been successfully developed1.Specifically,the COVID-19 ...
supported by the National Natural Science Foundation of China(No.82202603);the Scientific Research Plan Project initiated by the Tianjin Municipal Education Commission(No.2022ZD066,China);the Science and Technology Project of Tianjin Municipal Health Commission(No.TJWJ2021QN008,China).
Cancer remains a complex and challenging medical problem,driving extensive research efforts.Despite significant progress in understanding its genetic and molecular aspects,the quest for effective treatments continues....
the National Natural Science Foundation of China(82260695,82360781);the Jiangxi Provincial Natural Science Foundation(20232ACB206062);Jiangxi Provincial Department of Education(GJJ2400823);Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine(ZYYCXTD-D-202207);Young Jinggang Scholar of Jiangxi Province(Jing Zhang)and New Century Talents Project of Jiangxi Province(2017082,Xiang Li and 2020028,Jing Zhang);the Science and Technology Innovation Team of Jiangxi University of Chinese Medicine(CXTD22001 and CXTD22006);Jiangxi University of Traditional Chinese Medicine Special Zone Construction Project of Traditional Chinese Medicine(New Drug Creation Direction)(TQ-20).
Recently,immunotherapy has redefined cancer treatment by promoting the rapid killing of tumor cells through the immune system.Herbal medicines have been increasingly used as adjunct therapies to complement cancer trea...
supported by the National Natural Science Foundation of China(Nos.82073782 and 82241002);the Key Laboratory of Modern Chinese Medicine Preparation of Ministry of Education of Jiangxi University of Traditional Chinese Medicine(No.zdsys-202103)。
In recent years,there has been an increasing emphasis on exploring innovative drug delivery approaches due to the limitations of conventional therapeutic strategies,such as inadequate drug targeting,insufficient thera...
supported by the National Natural Science Foundation of China Youth Project(81900131);Tianjin Municipal Natural Science Foundation(18JCQNJC80400);Tianjin Education Commission Research Project(2018KJ043);Tianjin Education Commission Research Project(2018KJ045);Tianjin Science and Technology Planning Project(20YFZCSY00060);Tianjin Municipal Health Commission Youth Project(TJWJ2021QN001);the Medjaden Academy&Research Foundation for Young Scientists(MJR20221011);Tianjin Key Medical Discipline(Specialty)Construction project(XZDXK-028A);Tianjin Municipal Health Health Science and Technology Project(TJWJ2023XK003).
Multiple myeloma(MM)is an incurable malignancy of clonal plasma cells,characterized by high relapse rates and rapid development of drug resistance.The emergence of proteasome inhibitors has dramatically improved the t...
supported by the National Natural Science Foundation of China(Nos.52302343,81825007);Beijing Outstanding Young Scientist Program(No.BJJWZYJH01201910025030),Youth Beijing Scholar Program(No.010);Beijing Institute of Technology Teli Young Fellow Program(No.RCPT-20220029);the Beijing Institute of Technology Research Fund Program for Young Scholars(Nos.XSQD-6120220130,XSQD-202213001).
Skull defects are common in the clinical practice of neurosurgery,and they are easily complicated by encephalitis,which seriously threatens the life and health safety of patients.The treatment of encephalitis is not o...
Atherosclerosis is a severe cardiovascular disease followed by the accumulation of atherosclerotic plaques within the lumen of blood vessels resulting in reduced blood flow thus initiating a series of events.Conventio...
funded by Tianjin University of Traditional Chinese Medicine Startup Funding to Yunfei Li,and supported by Open Projects Fund of Shandong Key Laboratory of Carbohydrate Chemistry and Glycobiology,Shandong University(No.2023CCG13,China);funded by National Natural Science Foundation of China(No.82074030).
Tumor metastasis,the apex of cancer progression,poses a formidable challenge in therapeutic endeavors.Circulating tumor cells(CTCs),resilient entities originating from primary tumors or their metastases,significantly ...